Deciphex

About:

Deciphex uses digital pathology and AI to address the pathology productivity gap

Website: http://www.deciphex.com/

Twitter/X: @deciphex

Top Investors: Enterprise Ireland, Novartis, GI Partners, Charles River Laboratories International, Irrus Investments

Description:

Deciphex is an Irish-based software company focused on developing digital pathology-based solutions for clinical and research pathology. Our ambition is to deliver solutions that provide tangible productivity benefits to pathologists, eliminating low-level tasks so they can focus on the critical content. We believe that digital pathology combined with artificial intelligence will help make pathologists work more efficiently in the future, offering a solution to the pending challenges in supply/demand in pathology services. Deciphex plans to be at the forefront of this revolution with cleverly positioned solutions that deliver on the biggest problems facing pathology today.

Total Funding Amount:

$35.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dublin, Dublin, Ireland

Founded Date:

2017-01-01

Contact Email:

Info(AT)deciphex.com

Founders:

Donal O'Shea, Mairin Rafferty, Mark Gregson

Number of Employees:

101-250

Last Funding Date:

2023-10-16

IPO Status:

Private

© 2024 MyAiNote.com